ConversationBruno EschliHead of Investor Relations So welcome to our Pharma Day 2025 here in London. It's good to see here full house. I was told we have, I think, a record attendance here on site, and we also have quite a high number, I think, of web participants. So let me quickly take you through today's agenda and make a few upfront remarks before we kick off the event. Regarding the agenda, we will have again 2 sessions. We have a 2 hours morning session focused on strategy and the 2 hours, 10 minutes ...